Stockreport

BRIEF-Protalix Biotherapeutics' PRX-102 Granted Orphan Drug Designation By The European Commission [Reuters]

Protalix BioTherapeutics, Inc. (DE)  (PLX) 
PDF BRIEF-Protalix Biotherapeutics' PRX-102 Granted Orphan Drug Designation By The European Commission | Reuters Reuters Staff 1 Min Read Dec 27 (Reuters) - Protalix Biother [Read more]